These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8862226)

  • 1. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
    Stasch JP; Hirth-Dietrich C; Ganten D; Wegner M
    Am J Hypertens; 1996 Aug; 9(8):795-802. PubMed ID: 8862226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorenal consequences of dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibition in transgenic rats with an extra renin gene.
    Wegner M; Hirth-Dietrich C; Knorr A; Dressel J; Ganten D; Stasch JP
    Hypertens Res; 1996 Sep; 19(3):151-9. PubMed ID: 8891743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension.
    Takeda Y; Inaba S; Furukawa K; Fujimura A; Miyamori I; Mabuchi H
    J Hypertens; 2000 Jul; 18(7):927-33. PubMed ID: 10930191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P; Sisson D; Thomas W; Goetze L
    J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
    Stasch JP; Knorr A; Wegner M; Hirth-Dietrich C
    Hypertens Res; 1995 Jun; 18(2):137-43. PubMed ID: 7584920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin inhibition and endothelin-1 elevation: Focus on the kidney.
    Roksnoer LCW; Uijl E; de Vries R; Garrelds IM; Jan Danser AH
    Eur J Pharmacol; 2018 Apr; 824():128-132. PubMed ID: 29432709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
    Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
    Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
    Cheng ZJ; Finckenberg P; Louhelainen M; Merasto S; Tikkanen I; Vapaatalo H; Mervaala EM
    Eur J Pharmacol; 2003 Feb; 461(2-3):159-69. PubMed ID: 12586211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
    Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI
    Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a neutral endoprotease enzyme inhibitor, thiorphan, on hemodynamics and renal excretory function in four models of experimental hypertension.
    Pamnani MB; Chen S; Bryant HJ; Schooley JF; Haddy FJ; Ghai RD
    Clin Exp Hypertens; 2000 Jan; 22(1):45-62. PubMed ID: 10685724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.